M 1608 Adefovir dipivoxil Click here for Typical Certificate of Analysis |
|
| (bis(POM)-PMEA); (Bis(pivaloyloxymethyl)-9-[2-(phosphonomethoxy)ethyl]-adenine) |
|
| HPLC purified, Delivered ≥ 97% pure with dated HPLC UV chromatogram | |
| Solid | |
| Screwcap V-vial - shipped on dry ice | 1 mg $215 |
| M.W. 501.47 | 5 mg $565 |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MC 2034 Adefovir dipivoxil, [adenine-8-14C]- |
|
| (bis(POM)-PMEA, [adenine-8-14C]-); (Bis(pivaloyloxymethyl)-9-[2-(phosphonomethoxy)ethyl]-adenine, [adenine-8-14C]-) |
|
| Ethanol:water (1:1) solution, 500 µCi/ml | |
| > 50 mCi(1.85 GBq)/mmol | 10 µCi (370 kBq) $1240 |
| NextGen V-Vial - shipped on dry ice | 50 µCi (1.85 MBq) $3970 |
M.W. 501.47  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |
MT 1608 Adefovir dipivoxil, [adenine-8-3H]- |
|
| Click here for Typical Certificate of Analysis | |
| (bis(POM)-PMEA, [adenine-8-3H]-); (Bis(pivaloyloxymethyl)-9-[2-(phosphonomethoxy)ethyl]-adenine, [adenine-8-3H]-) |
|
| MORpure™ HPLC purified, Delivered ≥ 97% pure with dated HPLC radiochromatogram | |
| Ethanol:water (1:1) solution, 1 mCi/ml | |
| > 1 Ci(37 GBq)/mmol | 250 µCi (9.25 MBq) $1970 |
| NextGen V-Vial - shipped on dry ice | 1 mCi (37 MBq) $2915 |
M.W. 501.47  | |
| This material is pharmaceutically unrefined, and not intended for use in humans, clinical diagnosis, or data derived from its use to support regulatory filings. | |